|
1
|
Gacha-Garay MJ, Niño-Joya AF, Bolaños NI,
Abenoza L, Quintero G, Ibarra H, Gonzalez JM, Akle V and
Garavito-Aguilar ZV: Pilot study of an integrative new tool for
studying clinical outcome discrimination in acute leukemia. Front
Oncol. 9:2452019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Takahashi K, Wang F, Morita K, Yan Y, Hu
P, Zhao P, Zhar AA, Wu CJ, Gumbs C, Little L, et al: Integrative
genomic analysis of adult mixed phenotype acute leukemia delineates
lineage associated molecular subtypes. Nat Commun. 9:26702018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lennmyr E, Karlsson K, Ahlberg L, Garelius
H, Hulegårdh E, Izarra AS, Joelsson J, Kozlowski P, Moicean A,
Tomaszewska-Toporska B, et al: Survival in adult acute
lymphoblastic leukaemia (ALL): A report from the Swedish ALL
registry. Eur J Haematol. 103:88–98. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yi M, Li A, Zhou L, Chu Q, Song Y and Wu
K: The global burden and attributable risk factor analysis of acute
myeloid leukemia in 195 countries and territories from 1990 to
2017: Estimates based on the global burden of disease study 2017. J
Hematol Oncol. 13:722020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Malard F and Mohty M: Acute lymphoblastic
leukaemia. Lancet. 395:1146–1162. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hangai M, Urayama KY, Tanaka J, Kato K,
Nishiwaki S, Koh K, Noguchi M, Kato K, Yoshida N, Sato M, et al:
Allogeneic stem cell transplantation for acute lymphoblastic
leukemia in adolescents and young adults. Biol Blood Marrow
Transplant. 25:1597–1602. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tan J, Wang Y, Yu SJ, Ma YY, Lei HY and
Liu QF: Prognostic factors on graft-versus-host disease-free and
relapse-free survival after allogeneic hematopoietic stem cell
transplantation for adults with acute leukemia. Leuk Res. 59:1–7.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Halaburda K, Labopin M, Mailhol A, Socié
G, Craddock C, Aljurf M, Beelen D, Cornelissen JJ, Bourhis JH,
Labussière-Wallet H, et al: Allogeneic stem cell transplantation in
second complete remission for core binding factor acute myeloid
leukemia: A study from the acute leukemia working party of the
European society for blood and marrow transplantation.
Haematologica. 105:1723–1730. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Panebianco M, Bagni O, Cenfra N, Mecarocci
S, Ortu La Barbera E, Filippi L, Codacci-Pisanelli G, Biondi T,
Laghi A and Cimino G: Comparison of 18F FDG PET-CT AND CECT in
pretreatment staging of adults with Hodgkin's lymphoma. Leuk Res.
76:48–52. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou WL, Wu HB, Wang LJ, Tian Y, Dong Y
and Wang QS: Usefulness and pitfalls of F-18-FDG PET/CT for
diagnosing extramedullary acute leukemia. Eur J Radiol. 85:205–210.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stolzenburg A, Lückerath K, Samnick S,
Speer M, Kneer K, Schmid JS, Grigoleit GU, Hofmann S, Beer AJ,
Bunjes D, et al: Prognostic value of [18F]FDG-PET/CT in
multiple myeloma patients before and after allogeneic hematopoietic
cell transplantation. Eur J Nucl Med Mol Imaging. 45:1694–1704.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qiao W, Zhao J, Wang C, Wang T and Xing Y:
Predictive value of (18)F-FDG hybrid PET/CT for the clinical
outcome in patients with non-Hodgkin's lymphoma prior to and after
autologous stem cell transplantation. Hematology. 15:21–27. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Magnusson E, Cao Q, Linden MA, Frolich J,
Anand V, Burns LJ and Bachanova V: Hematopoietic cell
transplantation for mantle cell lymphoma: Predictive value of
pretransplant positron emission tomography/computed tomography and
bone marrow evaluations for outcomes. Clin Lymphoma Myeloma Leuk.
14:114–121. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Döhner H, Estey E, Grimwade D, Amadori S,
Appelbaum FR, Büchner T, Dombret H, Ebert BL, Fenaux P, Larson RA,
et al: Diagnosis and management of AML in adults: 2017 ELN
recommendations from an international expert panel. Blood.
129:424–447. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brown PA, Wieduwilt M, Logan A, DeAngelo
DJ, Wang ES, Fathi A, Cassaday RD, Litzow M, Advani A, Aoun P, et
al: Guidelines insights: Acute lymphoblastic leukemia, version
1.2019. J Natl Compr Canc Netw. 17:414–423. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Alam MS, Fu L, Ren YY, Wu HB, Wang QS, Han
YJ, Zhou WL, Li HS and Wang Z: 18F-FDG super bone marrow uptake: A
highly potent indicator for the malignant infiltration. Medicine
(Baltimore). 95:e55792016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
St-Pierre F, Broski SM, LaPlant BR, Ristow
K, Maurer MJ, Macon WR, Habermann TM, Ansell SM, Thompson CA,
Micallef INM, et al: Detection of extranodal and spleen involvement
by FDG-PET imaging predicts adverse survival in untreated
follicular lymphoma. Am J Hematol. 94:786–793. 2019.PubMed/NCBI
|
|
18
|
Papajík T, Mysliveček M, Urbanová R,
Buriánková E, Kapitáňová Z, Procházka V, Turcsányi P, Formánek R,
Henzlová L, Flodr P, et al: 2-[18F]fluoro-2-deoxy-D-glucose
positron emission tomography/computed tomography examination in
patients with chronic lymphocytic leukemia may reveal richter
transformation. Leuk Lymphoma. 55:314–319. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Albano D, Mazzoletti A, Spallino M, Muzi
C, Zilioli VR, Pagani C, Tucci A, Rossetti C, Giubbini R and
Bertagna F: Prognostic role of baseline 18F-FDG PET/CT metabolic
parameters in elderly HL: A two-center experience in 123 patients.
Ann Hematol. 99:1321–1330. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Valls L, Badve C, Avril S, Herrmann K,
Faulhaber P, O'Donnell J and Avril N: FDG-PET imaging in
hematological malignancies. Blood Rev. 30:317–331. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou M, Chen Y, Liu J and Huang G: A
predicting model of bone marrow malignant infiltration in
18F-FDG PET/CT images with increased diffuse bone marrow
FDG uptake. J Cancer. 9:1737–1744. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Michallet AS, Sesques P, Rabe KG, Itti E,
Tordot J, Tychyj-Pinel C, Baseggio L, Subtil F, Salles G, Dupuis JM
and Conte MJ: An 18F-FDG-PET maximum standardized uptake value
>10 represents a novel valid marker for discerning Richter's
Syndrome. Leuk Lymphoma. 57:1474–1477. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stölzel F, Röllig C, Radke J, Mohr B,
Platzbecker U, Bornhäuser M, Paulus T, Ehninger G, Zöphel K and
Schaich M: 18F-FDG-PET/CT for detection of
extramedullary acute myeloid leukemia. Haematologica. 96:1552–1556.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Arslan F, Yilmaz M, Cakir T and Mert A:
Significant contribution of Fluorodeoxyglucose positron emission
tomography/computed tomography (FDG PET/CT) in a case of acute
lymphoblastic leukemia presenting with fever of unknown origin.
Intern Med. 53:789–791. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Su K, Nakamoto Y, Nakatani K, Kurihara K,
Hayakawa N and Togashi K: Diffuse homogeneous bone marrow uptake of
FDG in patients with acute lymphoblastic leukemia. ClinNucl Med.
38:e33–e34. 2013.
|
|
26
|
Derlin T, Alchalby H, Bannas P, Veldhoen
S, Apostolova I, Triviai I, Bengel FM and Kröger N: Assessment of
bone marrow inflammation in patients with myelofibrosis: An
18F-fluorodeoxyglucose PET/CT study. Eur J Nucl Med Mol Imaging.
42:696–705. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jeong SY, Kim SJ, Pak K, Lee SW, Ahn BC
and Lee J: Prognostic value of 18F-fluorodeoxyglucose bone marrow
uptake in patients with solid tumors: A meta-analysis. Medicine
(Baltimore). 97:e128592018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Abe Y, Kitadate A, Usui Y, Narita K,
Kobayashi H, Miura D, Takeuchi M, O'uchi E, O'uchi T and Matsue K:
Diagnostic and prognostic value of using 18F-FDG PET/CT for the
evaluation of bone marrow involvement in peripheral T-cell
lymphoma. Clin Nucl Med. 44:e336–e341. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Khan AB, Barrington SF, Mikhaeel NG, Hunt
AA, Cameron L, Morris T and Carr R: PET-CT staging of DLBCL
accurately identifies and provides new insight into the clinical
significance of bone marrow involvement. Blood. 122:61–67. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hong J, Lee Y, Park Y, Kim SG, Hwang KH,
Park SH, Jeong J, Kim KH, Ahn JY, Park S, et al: Role of FDG-PET/CT
in detecting lymphomatous bone marrow involvement in patients with
newly diagnosed diffuse large B-cell lymphoma. Ann Hematol.
91:687–695. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen Y, Zhou M, Liu J and Huang G:
Prognostic value of bone marrow FDG uptake pattern of PET/CT in
newly diagnosed diffuse Large B-cell lymphoma. J Cancer.
9:1231–1238. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yoon HJ, Kim BS, Moon CM, Yoo J, Lee KE
and Kim Y: Prognostic value of diffuse splenic FDG uptake on PET/CT
in patients with gastric cancer. PLoS One. 13:e01961102018.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim SY, Moon CM, Yoon HJ, Kim BS, Lim JY,
Kim TO, Choe AR, Tae CH, Kim SE, Jung HK, et al: Diffuse splenic
FDG uptake is predictive of clinical outcomes in patients with
rectal cancer. Sci Rep. 9:13132019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mebius RE and Kraal G: Structure and
function of the spleen. Nat Rev Immunol. 5:606–616. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sharma Poudel B and Karki L: Abnormal
hepatic function and splenomegaly on the newly diagnosed acute
leukemia patients. JNMA J Nepal Med Assoc. 46:165–169.
2007.PubMed/NCBI
|
|
36
|
Nam HY, Kim SJ, Kim IJ, Kim BS, Pak K and
Kim K: The clinical implication and prediction of diffuse splenic
FDG uptake during cancer surveillance. Clin Nucl Med. 35:759–763.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sakellari I, Gavriilaki E, Batsis I,
Mallouri D, Gavriilaki M, Apostolou C, Iskas M, Voutiadou G,
Bouziana S, Bousiou Z, et al: Isolated extramedullary relapse as a
poor predictor of survival after allogeneic hematopoietic cell
transplantation for acute leukemia. Biol Blood Marrow Transplant.
25:1756–1760. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Støve HK, Sandahl JD, Abrahamsson J,
Asdahl PH, Forestier E, Ha SY, Jahnukainen K, Jónsson ÓG, Lausen B,
Palle J, et al: Extramedullary leukemia in children with acute
myeloid leukemia: A population-based cohort study from the nordic
society of pediatric hematology and oncology (NOPHO). Pediatr Blood
Cancer. 64:2017. View Article : Google Scholar
|
|
39
|
Kobayashi R, Tawa A, Hanada R, Horibe K,
Tsuchida M and Tsukimoto I; Japanese childhood AML cooperative
study group, : Extramedullary infiltration at diagnosis and
prognosis in children with acute myelogenous leukemia. Pediatr
Blood Cancer. 48:393–398. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bisschop MM, Révész T, Bierings M, van
Weerden JF, van Wering ER, Hählen K and van der Does-van den Berg
A: Extramedullary infiltrates at diagnosis have no prognostic
significance in children with acute myeloid leukaemia. Leukemia.
15:46–49. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kumar R, Harish N, Sharma A, Gupta RK,
Sharma A, Bakhshi S, Patel C, Thankarajan AS and Bal C: Comparison
of FDG PET/CT and CT in response assessment and prognosis of
patients with extra medullary disease in acute myeloid leukemia. J
Nucl Med. 60 (Suppl 1):S12512019.
|
